EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
EZH2 抑制作为治疗伴有 EZH2 激活突变的淋巴瘤的策略
期刊:Nature
影响因子:50.5
doi:10.1038/nature11606
Michael T McCabe, Heidi M Ott, Gopinath Ganji, Susan Korenchuk, Christine Thompson, Glenn S Van Aller, Yan Liu, Alan P Graves, Anthony Della Pietra 3rd, Elsie Diaz, Louis V LaFrance, Mark Mellinger, Celine Duquenne, Xinrong Tian, Ryan G Kruger, Charles F McHugh, Martin Brandt, William H Miller, Dash
